Businesses partner to ease patients’ access to therapeutic products for dermatology, in Asia
Healthcare companies DKSH Business Unit Healthcare (DKSH) and LEO Pharma have entered into an agreement to bring high-quality therapeutic products for dermatology and thrombosis to patients across Asia – partnering in Hong Kong, Malaysia, Singapore, Taiwan, Thailand, Vietnam, and the Philippines.
Skin diseases are notorious for causing serious physical and social discomfort for millions of patients around the world; whereas thrombosis is a chronic condition that can affect anyone regardless of their age, race, gender, and ethnicity.
To assist in their management, DKSH and LEO Pharma have agreed to build dedicated sales and marketing teams on the ground in Asia, and managing logistics and product distribution in these markets.
DKSH’s experienced teams and broad distribution network will ensure LEO Pharma products reach modern trade, traditional trade, hospitals, clinics, and other medical channels, as well as patients in need across the target region.
[The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices; LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. LEO Pharma offers a wide range of innovative treatments and therapies for all skin disease severities as well as thrombosis.]
Through the partnership, the two companies seek to solidify brand presence, grow market share, and ultimately improve patient health outcomes in Asia.
Khalid Aouidat, VP, responsible for commercial activities in Southeast Asia at LEO Pharma commented: “At LEO Pharma, we are dedicated to changing the standards of care for people with skin diseases by bringing new innovative treatments forward and making them easily accessible. Supporting this ambition, we are delighted to be partnering with DKSH. Their experience and strong regional footprint in Asia, as well as their marketing and sales expertise will help to further strengthen LEO Pharma’s brand and its continued growth.”
Bijay Singh, Head of Business Unit Healthcare at DKSH, said: “We are committed to enriching people’s lives and improving healthcare for all. The partnership with LEO Pharma strengthens our ambition to become the preferred partner for clients to help patients in Asia to have better access to high-quality and innovative products and solutions. While we drive their growth across the region, LEO Pharma can focus on researching and developing products and solutions for people with skin conditions.”
